People · Operator
Named in public records as an officer, director or promoter · active 2009–2018 · Biotech, Business Services
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Zivo Bioscience, Inc. | — | Biotech | Series A | $14.6M | $34.1M | 2009 |
| Northsight Capital, Inc. | — | Business Services | Series A | $8.8M | $4.7M | 2014 |
Howard Baer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Howard Baer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Gorman | 2 | 7 |
| JOHN PAYNE | 1 | 7 |
| John Venners | 1 | 3 |
| Thomas Dean | 1 | 3 |
| Peter Vitulli | 1 | 3 |
| BRIAN YOUNG | 1 | 3 |
| John B. Payne | 1 | 3 |
| THOMAS COX | 1 | 2 |
| John B Hollister | 1 | 2 |
| Keith R. Marchiando | 1 | 2 |
| Nola E. Masterson | 1 | 2 |
| Andrew A Dahl | 1 | 2 |
| John Hollister | 1 | 2 |
| Nola Masterson | 1 | 2 |
| Andrew Dahl | 1 | 2 |
| ROBERT RONDEAU | 1 | 1 |
| CHRISTOPHE MAGGIORE | 1 | 1 |
| Steven Warner | 1 | 1 |
| John Crissman | 1 | 1 |
| Janet Crance | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.